Skip to main content
Livermore
Livermore
ZHEN

D. E. Shaw & Co., Inc.

SEC CIK
0001009207
Latest filing
Aug 14, 2026

RDY holding history

Dr Reddys Laboratories Ltd in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

RDY overviewAll 13F holders of RDYFull Q2 2026 holdings

Shares (Q2 2026)
126,525
Value
$1.83M
% of portfolio
<0.1%
Quarters held
17
Since Q1 2021
Holdings of RDY by D. E. Shaw & Co., Inc., by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026126,525$1.83M<0.1%−12,026−8.7%ReducedHolders
Q1 2026138,551$1.92M<0.1%+96,927+232.9%AddedHolders
Q4 202541,624$584.4K<0.1%+41,624NewHolders
Q2 20250$00.0%−18,210−100.0%Sold outHolders
Q1 202518,210$240.2K<0.1%−411,677−95.8%ReducedHolders
Q4 2024429,887$6.79M<0.1%−173,353−28.7%ReducedConverted for a 5-for-1 splitHolders
Q3 2024120,648$9.59M<0.1%+120,648NewHolders
Q1 20240$00.0%−10,158−100.0%Sold outHolders
Q4 202310,158$706.8K<0.1%+10,158NewHolders
Q3 20230$00.0%−27,817−100.0%Sold outHolders
Q2 202327,817$1.76M<0.1%−110,385−79.9%ReducedHolders
Q1 2023138,202$7.87M<0.1%+65,444+89.9%AddedHolders
Q4 202272,758$3.77M<0.1%−16,409−18.4%ReducedHolders
Q3 202289,167$4.67M<0.1%−155,856−63.6%ReducedHolders
Q2 2022245,023$13.6M<0.1%−57,746−19.1%ReducedHolders
Q1 2022302,769$16.9M<0.1%+154,502+104.2%AddedHolders
Q4 2021148,267$9.70M<0.1%+59,722+67.4%AddedHolders
Q3 202188,545$5.77M<0.1%−66,631−42.9%ReducedHolders
Q2 2021155,176$11.4M<0.1%+27,227+21.3%AddedHolders
Q1 2021127,949$7.86M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.